Combined PFD and COC treatment yielded PPAR-γ levels of 146.67 ± 37.77, significantly higher than in the PCOS group (P < 0.0001), but not significantly different from PFD monotherapy (P ═ 0.197). This evidence concerns the gene PPARG and polycystic ovary syndrome.